Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer
The study objective is to provide data on the use of the Hedgehog signaling pathway inhibitor (vismodegib) in the treatment of recurrent locally advanced and metastatic basal cell skin cancer at the N. N. Petrov National Medical Research Center of Oncology.Materials and methods. Clinical data of 10...
Saved in:
| Main Authors: | Z. A.-G. Radzhabova, M. A. Kotov, Z. S. Bekyasheva, M. A. Radzhabova, E. V. Levchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-02-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/450 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern methods of treatment of locally-advanced and recurrent basal cell carcinoma of the head and neck with using signal pathway inhibitor Hedgehog: сlinical cases
by: A. P. Polyakov, et al.
Published: (2019-04-01) -
Long-Term Success in the Management of an Extensive Medial Canthal Basal-Cell Carcinoma with Vismodegib
by: Argyrios Tzamalis, et al.
Published: (2024-07-01) -
Hedgehog pathway inhibitors (HHI) combined with radiotherapy and immunotherapy for advanced basal cell carcinoma: a case report
by: Zhuren Ruan, et al.
Published: (2025-12-01) -
Multi-course photodynamic therapy of basal cell skin cancer of the central face area (clinical study)
by: E. V. Filonenko, et al.
Published: (2020-02-01) -
Clinical outcomes and adverse events of Hedgehog pathway inhibitors for advanced basal cell carcinoma patients: A systematic review and meta-analysis
by: Suvijak Untaaveesup, et al.
Published: (2025-01-01)